About STELARA

STELARA is a prescription medicine that contains the active ingredient USTEKINUMAB, which is used to treat certain chronic inflammatory diseases. STELARA works by targeting specific proteins in the body that are involved in inflammation and immune responses. By blocking these proteins, STELARA helps to reduce inflammation and prevent disease progression.

Key Benefits & Uses

Treatment of moderate to severe plaque psoriasis in adults and children aged 12 years and older
Treatment of active psoriatic arthritis in adults
Treatment of moderately to severely active Crohn's disease in adults

Active Ingredient & Action

USTEKINUMAB, the active ingredient in STELARA, is a human monoclonal antibody that binds to and blocks the action of two proteins, interleukin-12 (IL-12) and interleukin-23 (IL-23), which are involved in inflammation and immune responses. By blocking these proteins, USTEKINUMAB helps to reduce inflammation and prevent tissue damage.

Important Notes

STELARA should only be used under the guidance of a healthcare professional. Patients should be carefully evaluated for the presence of tuberculosis before starting treatment with STELARA. It is also important to note that STELARA may increase the risk of certain infections, such as upper respiratory tract infections. Patients should be advised to seek medical attention if they experience any signs of infection or other adverse effects.